Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
215.72
-0.30 (-0.14%)
At close: Jul 2, 2026, 4:00 PM EDT
217.50
+1.78 (0.83%)
After-hours: Jul 2, 2026, 7:49 PM EDT

Quest Diagnostics Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, Quest Diagnostics stock has a consensus rating of "Buy" and an average price target of $223.44. The average 1-year stock price forecast is 3.58% higher than the current stock price, while the lowest is $184 (-14.70%) and the highest is $245 (+13.57%).

Price Target: $223.44 (+3.58%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$184$223.44$225$245
Change-14.70%+3.58%+4.30%+13.57%

Analyst Ratings

The average analyst rating for Quest Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy777777
Buy222222
Hold889998
Sell110001
Strong Sell000000
Total181818181818

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 15, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$226
BuyMaintains$226+4.77%Jun 10, 2026
J.P. Morgan
J.P. Morgan
Hold
Maintains
$220
HoldMaintains$220+1.98%May 7, 2026
UBS
UBS
Hold
Maintains
$210$220
HoldMaintains$210$220+1.98%Apr 22, 2026
Truist Financial
Truist Financial
Hold
Maintains
n/a
HoldMaintainsn/an/aApr 22, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
11.85B
from 11.04B
Increased by 7.42%
Revenue Next Year
12.38B
from 11.85B
Increased by 4.42%
EPS This Year
10.77
from 9.85
Increased by 9.33%
EPS Next Year
11.67
from 10.77
Increased by 8.37%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
10.79B9.88B9.25B9.87B11.04B11.85B
Revenue Growth
14.32%-8.39%-6.39%6.70%11.78%7.42%
Gross Profit
4.22B3.45B3.07B3.27B3.68B3.94B
Gross Margin
39.09%34.93%33.14%33.15%33.33%33.22%
Operating Income
2.39B1.50B1.32B1.41B1.61B1.89B
Net Income
2.00B946.00M854.00M871.00M992.00M1.09B
EPS
----9.8510.77
EPS Growth
----10.30%9.33%
Forward PE
18.6118.9115.5315.9717.0720.03
Dividend / Share
2.482.642.843.003.203.21
Dividend Growth
-6.45%7.58%5.63%6.67%0.25%
Free Cash Flow
1.56B1.02B651.63M743.50M1.01B1.45B
No. Analysts
-----16
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High11.9B
Avg11.9B
Low11.8B

Revenue Growth

Revenue Growth202620272028
High
8.0%
Avg
7.4%
Low
6.8%

EPS Forecast

EPS202620272028
High11.11
Avg10.77
Low10.55

EPS Growth

EPS Growth202620272028
High
12.8%
Avg
9.3%
Low
7.1%